Stockwinners Market Radar for January 26, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
MMAT | Hot Stocks19:50 EST Meta Materials trading halted, news pending
|
INBS | Hot Stocks19:50 EST Intelligent Bio Solutions Inc trading halted, news pending
|
MKC | Hot Stocks18:48 EST McCormick CEO: 2024 will be a year of investment for us - In an interview on CNBC's Mad Money, Brendan Foley said McCormick will invest significantly in advertising and innovation in 2024. The focus will be on volume growth, he noted. Making sure products are at the right price point is key due to recent inflation, he added.
|
FICO | Hot Stocks18:38 EST FICO CEO: We definitely don't have a slowdown in our business - In an interview on CNBC's Mad Money, William Lansing said that Fair Isaac's investments in software are really paying off. He is not seeing a slowdown in business, and expects falling interest rates to benefit the company.
|
HII | Hot Stocks17:24 EST Huntington Ingalls awarded $913.15M Navy contract - Huntington Ingalls was awarded a $913.15M cost-plus-incentive-fee and cost-plus-fixed-fee contract for advanced planning and long-lead-time material procurement to prepare and make ready for the accomplishment of the USS Harry S. Truman Refueling and Complex Overhaul. Work is expected to be completed by June 2026. FY23 shipbuilding and conversion funds in the amount of $250M will be obligated at time of award and will not expire at the end of the current fiscal year. This contract was not competitively procured in accordance with 10 U.S. Code 3204(a)(1). The Naval Sea Systems Command is the contracting activity.
|
TSLA AMD | Hot Stocks16:52 EST Tesla CEO says 'yes' when asked if car maker plans to buy AMD chips - In a post on X, formerly Twitter, Tesla (TSLA) CEO Elon Musk responded "yes" to another user asking if the car maker has any plans to buy chips from AMD (AMD). Reference Link
|
DARE | Hot Stocks16:33 EST Dare Bioscience CFO Walters-Hoffert to retire - Dare Bioscience announced changes in company management which includes the retirement of Chief Financial Officer, Lisa Walters-Hoffert, and the resignation of Chief Commercial Officer, John Fair. Both Ms. Walters-Hoffert and Mr. Fair have entered into plans with the Company to help ensure a seamless transition. Dare also announced an adjustment to the size of its Board of Directors to better reflect the Company's size following the voluntary resignations of Cheryl R. Blanchard, Ph.D. and Sophia Ononye-Onyia, Ph.D. On January 23, 2024, Co-founder and Chief Financial Officer Lisa Walters-Hoffert informed Dare that she will retire from all positions with the Company, effective January 26, 2024. To help ensure a smooth transition of her responsibilities, Ms. Walters-Hoffert and the Company agreed that she will transition to a nine-month consulting role with the Company following her retirement. Given the financial knowledge and experience within the Dare team, the Company does not currently intend to appoint a chief financial officer, which further reduces costs for the Company over the long term as well. The functions performed by a chief financial officer will be performed by Ms. Johnson and MarDee Haring-Layton going forward. "As a result of Ms. Walters-Hoffert's retirement, Ms. Johnson, our Chief Executive Officer and President, will serve as our principal financial officer, and MarDee Haring-Layton, our current Vice President, Accounting & Finance, will serve as our Chief Accounting Officer," the company said. "Ms. Johnson has extensive experience as a finance executive, having previously served as Chief Financial Officer at WomanCare Global Trading, a specialty pharmaceutical company in female reproductive healthcare, and Cypress Bioscience, a publicly-traded pharmaceutical company."
|
PRGS | Hot Stocks16:29 EST Progress Software discloses subpoena from Office of DC Attorney General - According to a regulatory filing, on December 21, 2023, Progress Software received a preservation notice from the Federal Trade Commission, but has not otherwise received a request for information nor is Progress aware of any formal FTC investigation. On January 18, 2024, the companyreceived a subpoena from the Office of the Attorney General for the District of Columbia seeking various documents and information relating to the MOVEit Vulnerability. At this stage, the investigation is a fact-finding inquiry, and the investigation does not mean that Progress or anyone else has violated applicable laws. Progress intends to cooperate fully with the Office of the Attorney General for the District of Columbia in its investigation. "Such claims and investigations may have an adverse effect on how we operate our business and our results of operations, and in the future, we may be subject to additional governmental or regulatory investigations, as well as additional litigation or indemnification claims," Progress said. "Following the discovery of the MOVEit Vulnerability and the various remedial actions described here, we have discovered and patched additional vulnerabilities within the MOVEit Transfer and MOVEit Cloud platforms. While we are currently not aware of any evidence that these additional vulnerabilities were exploited by malicious threat actors, we cannot guarantee that we have or will uncover and/or address all vulnerabilities within the MOVEit platform or any of our other products prior to exploitation by threat actors. Our financial liability arising from any of the foregoing will depend on many factors, including the extent to which governmental entities investigate the matter and limitations contained within our customer contracts; therefore, we are unable at this time to estimate the quantitative impact of any such liability with any reasonable degree of certainty. As our fact-gathering investigation and litigation response continues, we will continue to assess the potential impact of the MOVEit Vulnerability on our business, operations, and financial results. Also, each of the governmental inquiries and investigations mentioned above could result in adverse judgements, settlements, fines, penalties, or other resolutions, the amount, scope and timing of which could be material, but which we are currently unable to predict."
|
GOL | Hot Stocks16:26 EST GOL Linhas trading halted, news dissemination
|
NUZE | Hot Stocks16:18 EST NuZee receives Nasdaq notification - NuZee announced that it has received a notice from the Listing Qualifications staff of The Nasdaq Stock Market notifying the company that the company's stockholders' equity as reported in its Annual Report on Form 10-K for the period ended September 30, 2023, did not satisfy the continued listing requirement under Nasdaq Listing Rule 5550(b)(1) for the Nasdaq Capital Market, which requires that a listed company's stockholders' equity be at least $2,500,000. In its Form 10-K, the company reported stockholders' equity of $1,674,357, and, as a result, does not currently satisfy Nasdaq Marketplace Rule 5550(b)(1).
|
GTLS | Hot Stocks16:17 EST Chart Industries still sees mid-teens organic revenue growth through 2026 - Chart Industries is reiterating its medium-term financial targets through 2026, which were originally presented at its Investor Day on November 28, 2023 and include: Mid-teens organic revenue growth through 2026; Reported gross profit margin of mid-30%'s in 2026; Double-digit adjusted diluted EPS growth CAGR of mid-40%'s; 95-100% Free Cash Flow Conversion. "We reiterate our medium-term financial targets, considering the recent news regarding the current pause of U.S. LNG export project approvals and timing," stated Jill Evanko, Chart's CEO and President. "Our medium-term outlook does not include any additional Big LNG projects that were not included in our September 30, 2023 backlog nor any awards related to the Department of Energy's $7 billion dollar Hydrogen Hub investment. Further, the addition of Howden to our portfolio in the first quarter 2023 further diversified our end-markets and full-solution offering, added geographic diversity and brought our aftermarket, service and repair business to over 30% of our annual revenue."
|
BKH | Hot Stocks16:17 EST Black Hills increases quarterly dividend to 65c per share - Black Hills announced that its board of directors approved a quarterly dividend of 65c per share, an increase of 2.5c per share over last quarter's dividend. Common shareholders of record at the close of business on Feb. 16 will receive $0.65 per share, payable March 1.
|
NRIM | Hot Stocks16:17 EST Northrim BanCorp expands share repurchase plan - Northrim BanCorp announced that its Board of Directors has authorized for repurchase up to an additional 110,000 shares of its common stock, or approximately 2% of the currently issued and outstanding shares.
|
TSE | Hot Stocks16:16 EST Trinseo announces price increase for PMMA cast sheets in Europe - Trinseo announced a price increase for acrylic sheet sold under the brand names ALTUGLAS and OROGLAS depending on grade specifications. Prices will be increased by +10% respectively for deliveries after February 1, and in accordance with existing agreements.
|
NSTB | Hot Stocks16:07 EST Northern Star Investment Corp II trading halted, news pending
|
X | Hot Stocks16:01 EST U.S. Steel reaches agreement for Clairton Plant incidents - United States Steel Corporation signed a Consent Decree with the Allegheny County Health Department, Clean Air Council, and PennEnvironment to address the Clairton Plant fire in 2018, and power outages at the Plant in 2019 and 2022. We regret that these accidental incidents occurred and believe this Consent Decree greatly benefits Mon Valley communities. Under the Consent Decree, U. S. Steel agrees to: Contribute $4.5 million to projects supporting public health and welfare and/or air quality improvement in the Mon Valley. Project funds will be managed and distributed by the Jefferson Regional Foundation and Allegheny County Department of Economic Development; Invest approximately $19.5 million in upgrades to coke oven gas cleaning facilities; Cover part of the litigation costs for PennEnvironment and Clean Air Council; Pay $500,000 to the Allegheny County Clean Air Fund; Permanently idle Battery #15 at Mon Valley Works - Clairton Plant, which has been on hot idle. The permanent idle will take place without job reductions. This permanent idling may lead to additional emissions reductions. U. S. Steel also agreed to a lower hydrogen sulfide limit in coke oven gas and other environmentally beneficial changes to facilities at the Clairton Plant. "At U. S. Steel, there are more than 3,000 hardworking men and women in the Mon Valley who strive every day to make essential steel in a way that complies with all environmental regulations. When we miss that mark, we will make changes so we can do better," said Kurt Barshick, Mon Valley Works Vice President. "We're glad that a significant amount of funds from this agreement will make their way back into the communities where we live and work."
|
DYN | Hot Stocks14:58 EST Dyne Therapeutics resumes trading, up 29% after report of takeover interest - Shares of Dyne Therapeutics are up $5.24, or 29%, to $23.14 after resuming trading.
|
DYN | Hot Stocks14:53 EST Dyne Therapeutics trading resumes
|
DYN | Hot Stocks14:32 EST Dyne Therapeutics jumps as Bloomberg says company seeing takeover interest - Shares of Dyne Therapeutics jumped in afternoon trading and were halted for volatility after Bloomberg reported that the company is considering its options as it receives takeover interest. The developer of drugs to treat muscle diseases has been speaking with advisers about possibilities, including a sale or partnership, people with knowledge of the matter told Bloomberg's Dinesh Nair and Michelle Davis. Following the report, the shares jumped 8% to $19.40 before being halted.
|
DYN | Hot Stocks14:28 EST Dyne Therapeutics trading halted, volatility trading pause
|
JCI | Hot Stocks14:25 EST Johnson Controls up 2% as Bloomberg says company weighing $5B in asset sales - Johnson Controls is working with advisers to explore a sale of a portfolio of heating and ventilation assets that could be valued at as much as $5B, people with knowledge of the matter told Bloomberg's Kiel Porter and Carmen Arroyo. In afternoon trading following the report, shares are up about 2%.
|
CINF | Hot Stocks14:17 EST Cincinnati Financial names Stephen Spray CEO - Cincinnati Financial Corporation announced that as of the May 4, 2024, Annual Meeting of Shareholders, President Stephen M. Spray will assume the title of chief executive officer of the company and all U.S. subsidiaries, completing the executive leadership transition that began when Spray was named president of the company in 2022. Steven J. Johnston will remain as executive chairman of the company and its U.S. subsidiaries. He'll continue to lead the board and support Spray by maintaining effective relationships with insurance agencies, investors, shareholders and other industry and business organizations. Johnston will also work with Spray and the board to establish long-range strategies. "Steve is the ideal candidate to lead the company forward," commented Steve Johnston, chairman and chief executive officer. "He's a thoughtful, strategic and proven leader with a deep understanding of how to maintain our industry-leading profitability and growth and of the value of the relationships we enjoy with our agents. Steve has an energy and enthusiasm for our business that is contagious. I'm confident in his abilities to bring innovative ideas together with the hallmarks of Cincinnati Insurance to produce value for shareholders far into the future." The company also announced that the board of directors at today's meeting added two new director seats, appointing Peter Wu as an independent director and Steve Spray as a nonindependent director. Additionally, Mr. Wu was appointed to the audit committee and Mr. Spray to the executive committee of the board, effective immediately. With these appointments, 10 of the company's 14 directors meet the Nasdaq listing requirements for independence.
|
CINF | Hot Stocks14:12 EST Cincinnati Financial raises quarterly cash dividend 8% to 81c per share - Cincinnati Financial announced that the board of directors declared an 81c per share regular quarterly cash dividend, increasing by 8% from the previous 75c per share dividend paid on January 16. The dividend is payable April 15 to shareholders of record as of March 19. Steven Johnston, chairman and CEO, commented, "Our long-term view for managing the company benefits Cincinnati Financial shareholders with value creation through various business and market cycles. Today's dividend increase reflects the board's and management's optimism for the ongoing success of our agency-centered strategy, delivered by our outstanding associates and backed by our superior financial strength. Shareholders have been rewarded consistently from dividend increases in each of the past 63 years, a record we believe is matched by only seven other U.S. publicly traded companies, and this board action sets the stage for continuing that record for a 64th year."
|
SPCE | Hot Stocks13:42 EST Virgin Galactic reports completion of eleventh successful spaceflight - Virgin Galactic announced the completion of its first spaceflight of 2024 and 11th mission to date. The "Galactic 06" flight marked the first time all four seats aboard VSS Unity were occupied by private astronauts, the company added. Michael Colglazier, CEO of Virgin Galactic, said: "Today the incredible team at Virgin Galactic supported another successful mission and delivered an unforgettable experience for four new astronauts. The success of 'Galactic 06' and the Company's other commercial spaceflights in recent months only increases our confidence in the repeatability of our product and our ability to deliver a superlative experience to our customers. With the production of our next-generation Delta-class ships underway, we look forward to expanding our flight capacity with testing expected to start next year and commercial service in 2026."
|
GRFS | Hot Stocks13:04 EST Grifols files lawsuit against Gotham City Research, seeks monetary relief - Grifols, S.A. hereby informs about the following: "As a continuation of the communication filed on January 10th, 2024 as a consequence of the Gotham report, Grifols wants to inform of the following: The Company filed a lawsuit in the United States District Court for the Southern District of New York against Daniel Yu, Gotham City Research LLC, General Industrial Partners LLP, Cyrus de Weck, and their affiliates to seek redress for the financial and reputational damages caused to the Company and its stakeholders as a consequence of the Defendants' actions. The complaint alleges that the Defendants amassed a large short position in Grifols, and then published and circulated a report with false statements about Grifols' accounting, disclosures, financial condition, and integrity. The Company is seeking injunctive and monetary relief through this lawsuit and intends to hold Defendants fully accountable for their wrongful conduct alleged in the complaint." Reference Link
|
BKR | Hot Stocks13:02 EST Baker Hughes reports U.S. rig count up 1 to 621 rigs - Baker Hughes reports that the U.S. rig count is up 1 from last week to 621 with oil rigs up 2 to 499, gas rigs down 1 to 119 and miscellaneous rigs unchanged at 3. The U.S. Rig Count is down 150 rigs from last year's count of 771 with oil rigs down 110, gas rigs down 41 and miscellaneous up 1 to 2. The U.S. Offshore Rig Count is down 1 to 19, up 6 year-over-year. The Canada Rig Count is up 7 from last week to 230, with oil rigs up 4 to 144, and gas rigs up 3 to 86. The Canada Rig Count is down 17 from last year's count of 247, with oil rigs down 13, and gas rigs down 4.
|
BKR | Hot Stocks13:02 EST Baker Hughes reports U.S. rig count up 1 to 621 rigs
|
CAT | Hot Stocks12:44 EST Caterpillar CFO Bonfield sells 10,000 common shares - In a regulatory filing, Caterpillar CFO Andrew Bonfield disclosed the sale of 10,000 common shares of the company on January 25 at a price of $300.04 per share.
|
PFE ALPMY | Hot Stocks12:01 EST EMA validates Type II variation application for Padcev-Keytruda combination - Pfizer (PFE) and Astellas Pharma (ALPMY) announced that on January 26 the European Medicines Agency validated for review a Type II variation application for PADCEV with KEYTRUDA as a combination therapy for the first-line treatment of adult patients with previously untreated locally advanced or metastatic urothelial cancer. If approved, PADCEV with KEYTRUDA has the potential to change the treatment paradigm, becoming the first combination treatment to offer an alternative to platinum-containing chemotherapy, the current standard of care in first-line la/mUC. Globally, approximately 573,000 new cases of bladder cancer and 212,000 deaths are reported annually.1 It is estimated that approximately 200,000 people in Europe are diagnosed with bladder cancer each year.
|
BFH | Hot Stocks12:00 EST Bread Financial rises 8.8% - Bread Financial is up 8.8%, or $2.88 to $35.52.
|
TV | Hot Stocks12:00 EST Televisa rises 10.4% - Televisa is up 10.4%, or 30c to $3.25.
|
BAH | Hot Stocks12:00 EST Booz Allen rises 13.3% - Booz Allen is up 13.3%, or $17.11 to $145.99.
|
ZIM | Hot Stocks12:00 EST ZIM Integrated falls -6.7% - ZIM Integrated is down -6.7%, or -92c to $12.88.
|
SOXL | Hot Stocks12:00 EST Direxion Daily Semiconductor Bull 3X Shares falls -6.7% - Direxion Daily Semiconductor Bull 3X Shares is down -6.7%, or -$2.50 to $34.62.
|
SAVE | Hot Stocks12:00 EST Spirit Airlines falls -12.6% - Spirit Airlines is down -12.6%, or -91c to $6.31.
|
BCS | Hot Stocks11:39 EST Texas AG says Barclays no longer permitted to underwrite state's municipal bonds - The Office of the Attorney General of Texas announced that Barclays would no longer be permitted to underwrite Texas's municipal bonds after failing to respond to requests for information concerning its "net zero" carbon emissions commitments. In an All Bond Counsel letter sent by the Office of the Attorney General on November 1, Barclays was identified as having a standing letter with the OAG while also being a Net Zero Alliance member or affiliate. This raised concerns that Barclays' activities may require it be classified as a "fossil fuel boycotter" under Texas law. When asked for more information concerning its ESG commitments, Barclays elected not to respond to the questions and acknowledged that by doing so it would likely forfeit its ability to contract with Texas governmental entities. Therefore, in accordance with Texas law, the OAG's Public Finance Division issued an All Bond Counsel Letter explaining that, "until further notice, we will not approve any public security issued on or after today's date in which Barclays purchases or underwrites the public security or is otherwise a party to a covered contract relating to the public security." Additionally, the letter notes, "As of today, we have not heard from any of the remaining banks under review that they will not be able to respond to our inquires." Reference Link
|
GATX | Hot Stocks11:02 EST GATX announces quarterly dividend increase to 58c per share - The board of directors of GATX Corporation declared a quarterly dividend of 58c per common share, payable Mar. 31, 2024, to shareholders of record on Mar. 3, 2024. GATX has paid quarterly dividends without interruption since 1919, and the dividend amount announced today represents a 5.5% increase from the prior year's dividend. "2024 marks our 106th consecutive year of paying a dividend, a track record few companies can match," said Robert C. Lyons, president and CEO of GATX. "In the past decade alone, GATX has invested $9.7B in our business while also returning over $1.5B to shareholders through dividends and share repurchases. This dividend increase reflects the board's positive view of GATX's long-term outlook, the strength and quality of our cash flows, and the company's ongoing commitment to shareholders."
|
CCL | Hot Stocks10:49 EST Carnival says Red Sea instability could impact operations - Carnival said in its annual filing: "We believe that the instability in the Red Sea region currently impacting shipping could have an impact on our results of operations."
|
JL | Hot Stocks10:41 EST J-Long Group Ltd trading resumes
|
JL | Hot Stocks10:36 EST J-Long Group Ltd trading halted, volatility trading pause
|
ZJYL | Hot Stocks10:31 EST Jin Medical International Ltd trading resumes
|
FLYX | Hot Stocks10:28 EST flyExclusive announces $25M strategic investment from ETG FE - flyExclusive announced the execution of a two-year revolving credit facility for up to $25.8 million with ETG FE LLC, an investment vehicle managed by EnTrust Global. As part of its strategic initiatives to accelerate operational excellence, grow the business, and execute its strategic plan to become the nation's first fully vertically integrated private aviation company, flyExclusive said it will use the proceeds to support the continued evolution of the company's fractional aircraft program. We believe this facility is a strong vote of confidence in flyExclusive's strategy and continued initiatives to increase growth and profitability," said Jim Segrave, Founder and CEO of flyExclusive.
|
ZJYL | Hot Stocks10:26 EST Jin Medical International Ltd trading halted, volatility trading pause
|
SAVE JBLU | Hot Stocks10:19 EST Spirit Airlines says JetBlue has no basis for terminating merger - This morning, JetBlue Airways (JBLU) filed an 8K stating that JetBlue yesterday informed Spirit Airlines (SAVE) that "certain conditions to closing required by the Agreement and Plan of Merger, dated as of July 28, 2022, among JetBlue, Spirit and Sundown Acquisition Corp., a Delaware corporation, and a direct wholly owned subsidiary of JetBlue may not be satisfied prior to the outside dates set forth in the Merger Agreement. JetBlue continues to evaluate its options under the Merger Agreement. Unless and until such time as the Merger Agreement is terminated pursuant to its terms, JetBlue will continue to abide by all of its obligations under the Merger Agreement," Spirit noted in its own regulatory filing. "Spirit believes there is no basis for terminating the Merger Agreement. Spirit will continue to abide by all of its obligations under the Merger Agreement, and it expects JetBlue to do the same," the company added.
|
KR | Hot Stocks10:05 EST Kroger to require all fresh produce suppliers to use Integrated Pest Management - The Kroger Co. announced a new goal to advance sustainability in its fresh produce supply chain, further protecting pollinators and biodiversity. Kroger will require all of its fresh produce suppliers to use Integrated Pest Management practices for all products supplied to Kroger by 2028 or 2030, based on the grower's size. Medium- to large-sized growers will be expected to meet the goal by the end of 2028, and small-sized growers by 2030.
|
MRK | Hot Stocks10:04 EST Merck announces results from Phase 3 AMBASSADOR/KEYNOTE-123 trial - Merck announced results from the Phase 3 AMBASSADOR/KEYNOTE-123 trial evaluating KEYTRUDA, Merck's anti-PD-1 therapy, for the adjuvant treatment of high-risk patients with localized muscle-invasive urothelial carcinoma and locally advanced resectable urothelial carcinoma. These late-breaking data are being presented for the first time today during an oral abstract session at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium. At the trial's first pre-specified interim analysis, after a median follow-up of 22.3 months, KEYTRUDA demonstrated a statistically significant and clinically meaningful improvement in one of the study's dual primary endpoints of disease-free survival, reducing the risk of disease recurrence or death by 31% versus observation in these patients after surgery. Median DFS was 29.0 monthsfor KEYTRUDA and 14.0 months for observation, an improvement of 15 months. These DFS results were consistent regardless of patients' PD-L1 expression status. The trial's other dual primary endpoint of overall survival did not reach statistical significance at the time of this interim analysis and will continue to be followed as data mature. After a median follow-up of 36.9 months, median OS was 50.9 months for KEYTRUDA versus 55.8 months for observation. Merck has an extensive clinical development program evaluating KEYTRUDA as monotherapy and in combination with other anti-cancer therapies across all stages of bladder cancer, including non-muscle-invasive, muscle-invasive and metastatic.
|
CWK | Hot Stocks10:02 EST Cushman & Wakefield enters collaboration with Measurabl - Cushman & Wakefield announced a strategic collaboration with Measurabl, a provider of environmental, social, and governance performance data solutions. This collaboration empowers Cushman & Wakefield's clients to access comprehensive ESG data seamlessly, providing a centralized platform to elevate their environmental efforts. This strategic combination of Measurabl's best-in-class ESG platform with Cushman & Wakefield's industry expertise, breadth of knowledge and understanding of ESG programs and requirements is an industry leading service offering.
|
BMI | Hot Stocks10:00 EST Badger Meter falls -6.8% - Badger Meter is down -6.8%, or -$10.32 to $142.00.
|
LPG | Hot Stocks10:00 EST Dorian LPG falls -7.1% - Dorian LPG is down -7.1%, or -$2.92 to $38.14.
|
SAVE | Hot Stocks10:00 EST Spirit Airlines falls -13.6% - Spirit Airlines is down -13.6%, or -98c to $6.24.
|
TV | Hot Stocks10:00 EST Televisa rises 6.8% - Televisa is up 6.8%, or 20c to $3.14.
|
ALUR | Hot Stocks10:00 EST Allurion Technologies rises 7.8% - Allurion Technologies is up 7.8%, or 24c to $3.30.
|
BAH | Hot Stocks10:00 EST Booz Allen rises 12.3% - Booz Allen is up 12.3%, or $15.86 to $144.74.
|
NUBI | Hot Stocks09:52 EST Nubia Brand International Corp trading resumes
|
GATX AIR | Hot Stocks09:51 EST GATX appoints AAR Corp. CEO John Holmes to board of directors - GATX Corporation (GATX) announced the election of John Holmes to its board of directors. Mr. Holmes will also serve as a member of the board's Audit Committee. With the appointment of Mr. Holmes, the GATX board will now consist of 10 members, including nine independent directors. Mr. Holmes is chairman, president and CEO of AAR CORP (AIR).
|
DAVE | Hot Stocks09:50 EST Dave Inc. trading resumes
|
USD | Hot Stocks09:47 EST VeriSign Inc falls -3.9% - VeriSign Inc is down -3.9%, or -$2.69 to $65.94.
|
SOXL | Hot Stocks09:47 EST Direxion Daily Semiconductor Bull 3X Shares falls -6.3% - Direxion Daily Semiconductor Bull 3X Shares is down -6.3%, or -$2.35 to $34.77.
|
SAVE | Hot Stocks09:47 EST Spirit Airlines falls -19.0% - Spirit Airlines is down -19.0%, or -$1.37 to $5.85.
|
OLN | Hot Stocks09:47 EST Olin rises 7.0% - Olin is up 7.0%, or $3.62 to $55.37.
|
BAH | Hot Stocks09:47 EST Booz Allen rises 8.6% - Booz Allen is up 8.6%, or $11.03 to $139.91.
|
ALUR | Hot Stocks09:47 EST Allurion Technologies rises 11.8% - Allurion Technologies is up 11.8%, or 36c to $3.42.
|
NUBI | Hot Stocks09:42 EST Nubia Brand International Corp trading halted, volatility trading pause
|
WNW | Hot Stocks09:41 EST Meiwu Technology Co Ltd trading resumes
|
RR | Hot Stocks09:40 EST Richtech Robotics Inc trading resumes
|
CRBP | Hot Stocks09:39 EST Corbus Pharmaceuticals trading resumes
|
WNW | Hot Stocks09:36 EST Meiwu Technology Co Ltd trading halted, volatility trading pause
|
RR | Hot Stocks09:35 EST Richtech Robotics Inc trading halted, volatility trading pause
|
CRBP | Hot Stocks09:34 EST Corbus Pharmaceuticals trading halted, volatility trading pause
|
DAVE | Hot Stocks09:32 EST Dave Inc. trading halted, volatility trading pause
|
BTBD | Hot Stocks09:07 EST BT Brands to pursue strategic alternatives for Bagger Dave's - BT Brands and its 39.6% owned affiliate, Bagger Dave's Burger Tavern, announced plans to review strategic alternatives for the Bagger Dave's public corporation and the six Bagger Dave's operating restaurant locations. As part of this review, it is anticipated that a proposal will be made to Bagger Dave's shareholders to change the name of Bagger Dave's to align the name appropriately with a new business strategy. The company anticipates proposing to shareholders a reverse split of Bagger Dave's outstanding shares, and plan to retain a PCAOB-registered audit firm to review the Bagger Dave's financial statements audited for inclusion in a potential equity offering registration statement, which would coincide with an uplisting of the shares to Nasdaq Markets or another exchange. Commenting on Bagger Dave's, CEO Gary Copperud noted, "All six stores are in excellent locations representing an original investment of more than $5 million. The stores range from 4,000 to 6,000 square feet, carry full liquor licenses, and are in excellent physical condition. We have had several restaurant professionals look at the locations over the last year, and all agree the units provide an outstanding footprint for a conversion opportunity. The Bagger Dave's locations will continue normal operations as Bagger Daves, with the process of conversion to another concept expected to begin sometime later this year. We look forward to identifying a dynamic growth opportunity, providing potential career growth for all current employees of Bagger Dave's. We see the opportunity for Bagger Dave's shareholders, including BT Brands, to earn significant returns from a successful conversion."
|
AYX | Hot Stocks09:02 EST Alteryx appoints Kevin Rubin as Interim CEO - Alteryx announced that its Board of Directors has appointed Kevin Rubin, the Company's CFO, to serve as Interim CEO. Rubin succeeds Mark Anderson, who has stepped down as CEO and from the Board of Directors to pursue other professional opportunities. With the support of the Company's finance organization, Rubin will continue to serve as CFO while serving as Interim CEO. Kevin Rubin is the CFO of Alteryx, responsible for all aspects of its global financial operations, including finance, accounting, tax, treasury, investor relations, corporate development and Alteryx Ventures, and global real estate and workplace services. He brings over 20 years of experience in the industry, leading both public and private technology companies through rapid growth and expansion. Prior to joining Alteryx in 2016, Rubin served as CFO of MSC Software, a private-equity backed software company.
|
AIHS | Hot Stocks09:01 EST Senmiao Technology reports ride-hailing platform metrics for December - Senmiao Technology announced the operating metrics for its proprietary online ride-hailing platform for the month of December 2023. In December 2023, Senmiao and its affiliates recorded approximately 0.55M total completed orders, a 13.6% increase from 0.48M total orders completed in November 2023. The increase was primarily a result of the recent strategic cooperation with Anhui Lianma Technology.
|
JBLU SAVE | Hot Stocks08:51 EST JetBlue says Spirit merger agreement may be terminable on and after January 28 - In a regulatory filing, JetBlue Airways (JBLU) disclosed that yesterday the company informed Spirit Airlines (SAVE) that certain conditions to closing required by the agreement and plan of merger, dated as of July 28, 2022, among JetBlue, Spirit and Sundown Acquisition Corp., a Delaware corporation, and a direct wholly owned subsidiary of JetBlue, may not be satisfied prior to the outside dates set forth in the merger agreement and also informed Spirit that accordingly the merger agreement may be terminable on and after January 28, 2024. "JetBlue continues to evaluate its options under the Merger Agreement. Unless and until such time as the Merger Agreement is terminated pursuant to its terms, JetBlue will continue to abide by all of its obligations under the Merger Agreement," the company added. Reference Link
|
RIBT | Hot Stocks08:50 EST RiceBran sell Golden Ridge milling facility for $2.15M - RiceBran Technologies has sold its Golden Ridge rice mill located in Wynne, Arkansas for $2.15M. The divestiture is expected to, based upon third quarter 2023 results, further narrow RiceBran's projected annual net loss by approximately $1.5M while not jeopardizing the estimated $54.4M in federal and $46M in state net operating loss carryforwards that the Company had amassed as of December 31, 2022. "This sale eliminates cash and working capital drags on the business' profitability, streamlining operations while preserving the Company's net operating loss carryforward assets," commented Eric Tompkins, RiceBran's Executive Chairman. "We continue to own and operate MGI, our barley and oats mill located in East Grand Forks, Minnesota. This transaction is the advancement of the strategic restructuring process undertaken by the Board of Directors. Today, RiceBran has streamlined its business and balance sheet, eliminating unprofitable operations. We can now shift our attention to RiceBran's future, as we explore a more sustainable way to take advantage of our tax assets and public listing to create value for shareholders."
|
CMLS | Hot Stocks08:49 EST Cumulus Media's Westwood One to broadcast NFL Conference Championship - Cumulus Media's Westwood One will present live play-by-play coverage of NFL Conference Championship Sunday, presented by Intuit Turbo Tax. Doubleheader coverage will begin with the pregame show at 2:00 p.m. ET on Sunday, January 28 before the Kansas City Chiefs and the Baltimore Ravens meet for the AFC Championship game and the Detroit Lions battle the San Francisco 49ers in the NFC Championship game.
|
FSTR | Hot Stocks08:48 EST L.B. Foster enters cooperation agreement with 22NW, nominates Jones for board - L.B. Foster Company announced that, pursuant to the Cooperation Agreement dated January 25, 2024 between the company and 22NW, LP, the company's largest shareholder, and certain affiliated persons thereof, the company will nominate Mr. Alexander Jones for election to its eight-member Board of Directors at the 2024 Annual Meeting of Shareholders. Mr. Jones will fill the vacancy created by the retirement of Mr. Dirk Junge who cannot stand for reelection to the L.B. Foster Board under the terms of the Company's Corporate Governance Guidelines. Mr. Jones has served as a Board Observer at the company since April of 2023 pursuant to a prior Cooperation Agreement dated April 6, 2023, that the Company entered into with 22NW, LP and certain affiliated persons thereof. Mr. Jones is a Vice President and Senior Research Analyst at 22NW, LP, where he oversees the firm's investments in the industrials, materials, and consumer sectors. Mr. Jones will continue in his role as a Board Observer through the 2024 Annual Meeting. Pursuant to the Cooperation Agreement, L.B. Foster and 22NW have also agreed to customary standstill, voting, confidentiality, and other provisions.
|
NVTS | Hot Stocks08:34 EST Navitas Semiconductor announces 'Planet Navitas' at APEC 2024 - Navitas Semiconductor invites visitors to experience "Planet Navitas" and collaborate to "Electrify Our World" at APEC 2024. Following the mission to "Electrify our World", the "Planet Navitas" exhibition booth invites visitors to discover how next-gen GaN and SiC technology enable the latest solutions for fully-electrified housing, transportation and industry. Examples range from TV power to home-appliance motors and compressors, EV charging, solar/micro-grid installations, and on to data center power systems. Each example highlights end-user benefits, such as increased portability, longer range, faster charging, and grid-independence, plus a focus on how low-carbon-footprint GaN and SiC technology can save over 6 Gtons/yr CO2 by 2050.
|
GNE | Hot Stocks08:32 EST Genie Energy announces formation of 'captive' self-insurance subsidiary - Genie Energy announced an expansion of its consumer product portfolio and the formation of a "captive" self-insurance subsidiary to enhance the Company's risk management strategy. Genie announced that it has formed a wholly-owned captive insurance subsidiary. In the fourth quarter of 2023, Genie paid this captive entity $51 million in premiums for insurance coverage of various risks. As required by GAAP, Genie will record a one-time, non-recurring, non-cash charge of approximately $45 million in the fourth quarter as an insurance loss reserve related to the coverage provided to Genie by the captive entity. While this loss reserve will be reflected in Genie's financial results under GAAP, the Company does not expect this charge to impact its Adjusted EBITDA results for the fourth quarter or full year 2023. The $51 million in premium payments to the "captive" insurance subsidiary will remain on Genie's consolidated balance sheet within its reported measure of consolidated cash, restricted cash, and marketable equity securities. The funds will be available for investment as determined by Genie management to support the Company's corporate strategic objectives. Genie expects to report a year-end 2023 balance of approximately $165 million in consolidated cash, restricted cash, and marketable equity securities, compared to $121 million at year-end 2022. The expected figure is an estimate and is subject to change as Genie completes its fourth quarter and full-year financial statements and the audit of its annual statements.
|
SPWH | Hot Stocks08:27 EST Sportsman's Warehouse appoints Steven Becker to board of directors - Sportsman's Warehouse Holdings announced that Steven Becker has been appointed as an independent member of its Board of Directors, effective immediately. He will serve as a member of the Board's Nominating and Governance Committee. Becker most recently served in various roles with Tuesday Morning Corp., including as CEO and a member of the board of directors from December 2015 until May 2021.
|
CEM... | Hot Stocks08:19 EST Clearbrdige Energy MLP Funds announce proposed merger, updated tender offers - ClearBridge MLP (CEM), ClearBridge Energy Midstream Opportunity Fund (EMO), ClearBridge MLP and Midstream Total Return Fund (CTR) (individually, a Fund and collectively, the Funds) announced approval by each Fund's board of directors of a proposal to merge CEM with and into EMO and CTR with and into EMO, subject to approval by stockholders of each fund. The approval of each individual merger is not contingent upon the approval of the other merger. If approved, the mergers are expected to occur during the third quarter of 2024. If the proposed mergers are approved by the stockholders of each Fund, common stockholders of CEM and CTR would receive shares of common stock of EMO, based on each Fund's respective net asset value per share and holders of CEM's and CTR's mandatory redeemable preferred stock, or MRPS, would receive shares of MRPS of EMO with the same aggregate liquidation preference and terms to their respective MRPS. In lieu of issuing fractional shares of common stock, EMO will pay cash to each former common stockholder of CEM and CTR in an amount equal to the value of the fractional shares of EMO common stock that the investor would otherwise have received in the merger. Management and each Fund's investment adviser do not anticipate any material portfolio turnover as a result of the proposed merger. The merger is expected to qualify as a tax-free reorganization for federal income tax purposes. Each Fund's board also determined that it is advisable and in the best interest of each Fund to repeal such Fund's election to be subject to the Maryland Control Share Acquisition Act under Maryland General Corporation Law. Each Fund's board approved an amendment to the current Third Amended and Restated Bylaws of each Fund to remove such Fund's election to be subject to the Control Share Act, effective as of January 25. As previously announced, prior to the completion of the mergers, CEM, EMO and CTR will conduct tender offers that are expected to commence on or about May 21, 2024 for up to 50% of such Fund's outstanding Shares at a price per share equal to 100% of the Fund's net asset value as of the business day immediately following the expiration date of the tender offer. CEM, EMO and CTR will repurchase Shares tendered and accepted in the tender offer in exchange for cash. Each Fund's tender offer period is expected to close on or about June 18. In the event a tender offer is oversubscribed, Shares will be repurchased on a pro rata basis.
|
MMAT | Hot Stocks08:15 EST Meta Materials 'focused on driving revenue growth' in 2024 - The company said, "The Company is focused on driving revenue growth in 2024 across four main business lines. In authentication, META has launched two new products, QUANTUM stripe for currency and NANO protect for brand protection, along with continued work for our confidential G10 central bank customer. Following presentations at the Dubai Air Show in November 2023, META is working on multiple pre-orders for the VLEPSIS multi-gigapixel wide area motion imagery system. The Company's NANOWEB transparent conductive films are manufactured in collaboration with Panasonic Industry. Automotive heating films to protect camera, radar and lidar sensors are being tested by leading automotive OEMs and suppliers. NANOWEB EMI shielding films for microwave and combination microwave-convection ovens are also in advanced stages of testing. META is also pursuing joint development and licensing opportunities with global battery OEMs for our NPORE nanoceramic battery separators and NCORE polymer metal composite current collectors."
|
WIMI | Hot Stocks08:11 EST WiMi Hologram Cloud develops AI-driven spatial interaction perception system - WiMi Hologram Cloud developed an AI-driven real-time spatial interaction perception system for interior design. The design industry has ushered in the era of personalized design, and the co-use of AI and VR technologies provides an unprecedented opportunity. Through advanced AI algorithms, WiMi's AI-driven real-time spatial interaction perception system for interior design realizes the perception enhancement of the virtual environment. Users are not only able to see virtual furniture, but also perceive elements such as walls and floors in the virtual space.
|
INSP | Hot Stocks08:10 EST Inspire Medical announces Griffin to retire from board of directors - Inspire Medical Systems announced the retirement of Jerry Griffin, M.D., from its Board of Directors, to be effective at the conclusion of the Company's Annual Meeting of Stockholders scheduled to occur on May 2, 2024. Dr. Griffin has served on the Inspire Board of Directors since 2008 and was one of the original board members, having joined Inspire prior to the initial Series A financing.
|
PHUN | Hot Stocks08:10 EST Phunware appoints Han to its board of directors - Phunware announced the appointment of Elliot Han to its Board of Directors on January 21, 2024. Han brings extensive experience to Phunware's board. He currently serves as a Partner at PGP Capital Advisors, a boutique investment/merchant bank where he focuses on mergers & acquisitions and corporate finance both in the domestic and international arena.
|
NSC | Hot Stocks08:09 EST Norfolk Southern CEO says entering 2024 with 'positive momentum' - Norfolk Southern President and CEO Alan Shaw said, "The fourth quarter marked the end of a challenging, yet transformational year for Norfolk Southern. I'm proud that the team responded with unwavering dedication while continuing to advance our strategy that strikes the necessary balance between service, productivity and growth. We invested in our people, enhanced our service performance and made a safe railroad even safer. Norfolk Southern enters 2024 with positive momentum and a focus on driving further productivity gains and operational discipline through aggressive cost management. We see growth on the horizon, and we are confident in our ability to deliver industry-competitive margins over time."
|
FEMY | Hot Stocks08:09 EST Femasys begins enrollment for FemBloc trial - Femasys announced that it has activated enrollment for its FemBloc trial at University of California, Davis Medical Center in Sacramento, California. The FemBloc Intratubal Occlusion for TranscervicAL Permanent Birth Control is being conducted to investigate the safety and efficacy of its investigational permanent birth control candidate, FemBloc. The FDA-approved, multi-center trial is designed to address the high unmet need that exists for women seeking permanent birth control, for whom elective surgery currently remains the only option. "UC Davis Medical Center, a nationally renowned medical center, is another great addition to the clinical trial sites participating in this initial phase of the FINALE trial, as Dr. Mitchell Creinin has been a long-time supporter of our new permanent birth control option," said Kathy Lee-Sepsick, founder, president and chief executive officer of Femasys.
|
NXST | Hot Stocks08:07 EST Nexstar increases quarterly dividend 25% to $1.69 per share - Nexstar announced that its board of directors approved a 25% increase to its quarterly cash dividend to $1.69 per share beginning with the dividend declared for the first quarter of 2024. The dividend is payable on Friday, February 23 to shareholders of record on Friday, February 9.
|
GRI | Hot Stocks08:07 EST GRI Bio announces 1-for-7 reverse stock split - GRI Bio announced that the board of directors of the Company approved a 1-for-7 reverse stock split of the Company's common stock. The Reverse Split was approved by the stockholders of the Company at a special meeting of the Company held on January 19, 2024. The Reverse Split will legally take effect at 4:01 p.m. Eastern Time, on January 29, 2023. The Company's common stock will open for trading under a new CUSIP number 3622AW 205 on The Nasdaq Capital Market on January 30, 2024, on a split-adjusted basis under the current ticker symbol "GRI." The Reverse Split is intended to increase the per share trading price of the Company's common stock to enable the Company to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market.
|
MOG... | Hot Stocks08:06 EST Moog increases quarterly dividend 4% to 28c per share - The board of directors of Moog declared a quarterly dividend of 28c per share on the company's issued and outstanding shares of Class A and Class B common stock, a 4% increase over the previous quarter's dividend. The dividend will be paid on February 27 to all shareholders of record as of the close of business on February 9. The dividend represents a use of cash of approximately $9M. Future declarations of quarterly dividends are subject to the determination and discretion of Moog's board of directors.
|
FHB | Hot Stocks08:03 EST First Hawaiian board adopts $40M stock repurchase program - The Company's Board of Directors adopted a stock repurchase program for up to $40 million of its outstanding common stock during 2024.
|
PLNHF | Hot Stocks07:36 EST Planet 13 Holdings to restate previously issued financial statements - Planet 13 Holdings announced that, as a result of the preliminary information obtained in connection with an ongoing internal investigation, the Audit Committee of the Board of Directors of the Company, based on the recommendation of the Company's management, and after consultation with the Company's independent registered public accounting firm, concluded that the Company's previously issued audited consolidated financial statements as of and for the years ended December 31, 2022 and 2021 included in the Company's Annual Report on Form 10-K for the year ended December 31, 2022 and the Company's previously issued unaudited consolidated financial statements included in the Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023, June 30, 2023 and September 30, 2023 should no longer be relied upon due to material errors due to the believed misappropriation of approximately $22.0 million of the Company's funds held by El Capitan Advisors, as disclosed in the news release issued by the Company dated January 23, 2024. El Capitan is an investment advisor registered with the Securities and Exchange Commission that was engaged by the Company on June 20, 2021 for cash management services. Similarly, any previously furnished or filed reports, related earnings releases, related management's discussion and analysis of financial condition and results of operations, investor presentations or similar communications of the Company describing relevant portions of the Affected Financials should no longer be relied upon. The Company intends to file amendments to the Reports, including restated financial statements and related disclosures as promptly as practicable.
|
PRZO | Hot Stocks07:34 EST ParaZero enables light UAS operator certficate approval in Denmark - ParaZero Technologies has facilitated one of its customers in obtaining the first-ever light uncrewed aircraft system operator certificate in Denmark. The LUC is an organizational approval certificate granted by the European Union Aviation Safety Agency, which is an agency of the European Union with responsibility for civil aviation safety, that allows for cross-border operations throughout the EU without additional approval required, enabling flight operations to be self-authorized by the LUC holder anywhere throughout EASA member states. Additionally, the LUC holder may operate a variety of UAS platforms under one single approval, offering a quantum change in the efficiency of drone aerial services, while maintaining safe operating conditions. The ParaZero SafeAir parachute system was utilized throughout the LUC application process to enable a broader range of advanced flight permissions, including operations over people, considered to be a highly sought-after flight permission.
|
BFRG | Hot Stocks07:33 EST Bullfrog AI adds Gwenn Smith, Jeremiah Wala to Scientific Advisory Board - BullFrog AI Holdings announced the appointment of two scientific advisors to its advisory board: Gwenn S. Smith, PhD, and Jeremiah Wala, MD, PhD. Dr. Smith, the Richman Professor of Psychiatry and Behavioral Sciences and Radiology at Johns Hopkins University School of Medicine, brings a wealth of expertise in brain imaging and neuropsychiatry. Dr. Wala, a physician-scientist, computational biologist, and senior medical oncology fellow at Dana-Farber Cancer Institute, adds a unique blend of clinical insight and computational expertise to BullFrog AI's scientific advisory board.
|
CRBP | Hot Stocks07:32 EST Corbus Pharmaceuticals announces data from study of CRB-701 - Corbus Pharmaceuticals announced that data from the first-in-human clinical study of CRB-701 is being presented as a poster by the Company's development partner CSPC Pharmaceutical Group at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium. The Phase 1 dose escalation study is being conducted in China and is enrolling participants with metastatic urothelial cancer as well as participants with other solid tumors prospectively confirmed to have nectin-4 positive tumors. Safety: CRB-701 was well-tolerated with the majority of adverse events being grade one or two and reversible. No adverse events above grade three were observed. There have been no dose discontinuations or reductions in the study to date. There has been a singular participant that experienced a temporary dose interruption. No cases of drug-related peripheral neuropathy or skin rash have been reported to date. PK: Single dose PK suggested that TAb, ADC and MMAE increase in an approximate dose proportional manner. No obvious accumulation was observed on cycle 3, day 1. When compared to the exposures achieved with enfortumab vedotin at 1.25 mg/kg Q1W x21 days, CRB-701 consistently demonstrated lower free MMAE concentrations. Efficacy: Dose level 5 and above represents the predicted therapeutically relevant doses based on allometric scaling. A mixed tumor population receiving doses of 2.7 mg/kg or 3.6 mg/kg demonstrated an ORR of 43% and a disease control rate of 71%. The longest observed response to date is 11 cycles and ongoing. All nectin-4 positive mUC and cervical patients at doses greater than or equal to 2.7 mg/kg that were assessable at the time of the December 2023 data-cut off demonstrated levels of disease control and represent the CRB-701 responsive population to date.
|
APCX | Hot Stocks07:31 EST AppTech Payments enters partnership with First Inning Ventures - AppTech Payments announces a strategic partnership with First Inning Ventures, an international sports marketing and consulting agency. Luke D'Angelo, AppTech CEO, commented, "The collaboration with First Inning aligns seamlessly with our vision to drive new revenue within addressable markets ripe for transformative growth. We look forward to working closely with FIV to leverage their extensive relationship infrastructure to help scale the user base of our Specialty Payments platform while building long-term shareholder value."
|
BMY | Hot Stocks07:15 EST Bristol Myers announces CHMP opinion for Abecma - Bristol Myers announced the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, has recommended marketing authorization approval of Abecma for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior therapies, including an immunomodulatory agent, or IMiD, a proteasome inhibitor, or PI, and an anti-CD38 monoclonal antibody. The European Commission, or EC, which has the authority to approve medicines for the European Union, or EU, will now review the CHMP recommendation.
|
APLS | Hot Stocks07:07 EST Apellis announces negative CHMP opinion for pegcetacoplan for GA - Apellis Pharmaceuticals announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a negative opinion on the marketing authorization application of intravitreal pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration. As previously announced, this opinion was expected based on a negative trend vote following an oral explanation meeting in December 2023. Apellis plans to seek immediate re-examination of its application. "We are very disappointed in this outcome on behalf of the millions of Europeans with GA who currently have no treatment options for this irreversible form of blindness," said Jeffrey Eisele, Ph.D., chief development officer, Apellis. "We plan to promptly initiate the re-examination of our application and address CHMP questions, with the goal of bringing this first-ever potential treatment to the GA community in Europe." The MAA is based on results from the Phase 3 OAKS and DERBY studies at 24 months, which were published in The Lancet. Treatment with both every-other-month and monthly pegcetacoplan reduced GA lesion growth with increasing treatment effects over time and showed a well-demonstrated safety profile. Additionally, pegcetacoplan preserved visual function longer in multiple post hoc Phase 3 analyses that have been presented at medical congresses.
|
AXP | Hot Stocks07:05 EST American Express to increase quarterly dividend 17% to 70c per share - The company plans to increase the regular quarterly dividend on its common shares outstanding by 17%, from 60c to 70c per share, beginning with the first quarter 2024 dividend declaration.
|
NTRB | Hot Stocks07:04 EST Nutriband CEO says 2024 goals are 'ambitious yet achievable' - Nutriband announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on achievements and targets through 2023 and the potential outlook for 2024. The letter read in part, "As we wrapped up a successful 2023 and our annual shareholder meeting this week, the entire team at Nutriband would like to extend our warmest appreciation to all of you for your continued support throughout the year and into 2024. Many of you have been with us from the beginning and many more joined our common goal along the way. This goal is to change the world for the better by creating technology designed to improve the safety standard of easily abused transdermal drugs while simultaneously focusing on making these safer treatments available to patients who require them. Your support has been paramount as we strive to reduce potential dilution to shareholders, a primary goal of the management team. We have dedicated ourselves to developing a portfolio of transdermal pharmaceutical products and made significant strides these past 12 months showcasing AVERSA in London and garnering recognition for our innovative technology by peers in the pharmaceutical field, receiving multiple award nominations at the 2023 Pharma industry awards...Financially, the team is excited by strong revenue growth reported in 2023 from our Pocono Pharma subsidiary which we are working to improve upon further in 2024. Pocono and our subsidiaries are an important part of our company structure to reduce our burn rate through the clinical development process. We have recently strengthened our balance sheet converting $2 million of debt into equity with a large strategic shareholder as outlined in recent filings.Our marketing initiatives, particularly the collaboration with KT Tape, are expected to significantly expand our potential revenue growth for 2024. In 2023, we also launched our own Active Intelligence. Brand portfolio simultaneously announcing Ex NFL Quarterback Donovan McNabb as brand ambassador. This new line includes our new Heating and Cooling Kinesiology Tape. All AI Tape products are manufactured in the USA at Nutriband's facility in Cherryville, North Carolina, and are available for purchase on Amazon and Activeintell.com. These new initiatives have expanded our revenue opportunities, reducing our potential capital needs as we continue the development of AVERSA and its regulatory pathway. Our 2024 goals are ambitious yet achievable, focused on FDA pre-IND and IND meetings in the near term, the HAL Study for Aversa Fentanyl, new potential partnerships, and targeting an NDA submission before our Year End...Your continued support and belief in our vision have been pivotal to our reaching these milestones and others as we forge ahead. We remain committed to delivering innovative solutions and generating value for our shareholders. Thank you for your trust, confidence and investment in Nutriband."
|
CL | Hot Stocks07:00 EST Colgate-Palmolive reports Q4 base gross profit margin up 400 bps to 59.6% - Q4 GAAP Gross profit margin and Base Business Gross profit margin both increased 400 basis points to 59.6%.
|
CL | Hot Stocks06:59 EST Colgate-Palmolive 'well positioned' to deliver compounded EPS growth in FY24 - Noel Wallace, Chairman, President and CEO, commented on the Base Business fourth quarter and full year results, "We are pleased to have finished the year with another quarter of strong top and bottom line results including 7.0% net and organic sales growth, improved organic volume performance, gross and operating profit margin expansion and double-digit earnings per share growth. For the full year, we grew both net and organic sales 8.5%, with organic sales growth in every division and in all four of our categories. This was our fifth consecutive year with organic sales growth at or above our 3% to 5% targeted range. The strong sales growth combined with our commitment to productivity and efficiency drove strong bottom line performance as well, with gross profit, gross profit margin, operating profit, operating profit margin, net income, earnings per share and free cash flow all increasing versus 2022 for both the quarter and the year. We continued to invest in the capabilities required to deliver robust growth going forward, building strength in areas like innovation, digital, data and analytics, revenue growth management and advertising. We leveraged our strong margin performance to invest behind building our brands, with a 19% increase in advertising spending in 2023, and we expect higher levels of brand investment in 2024. The quality of our results this year and our strong growth momentum, including improved organic volume performance, add to our confidence that we are well positioned to deliver consistent, compounded earnings per share growth in 2024 and beyond."
|
BAH | Hot Stocks06:50 EST Booz Allen raises FY24 net cash from operations to $200M-$275M from $160M-$260M
|
SHEL | Hot Stocks06:50 EST Shell invests to repurpose German Energy, Chemicals Park Rheinland - Shell Deutschland GmbH has taken a final investment decision, FID, to convert the hydrocracker of the Wesseling site at the Energy and Chemicals Park Rheinland into a production unit for Group III base oils, used in making high-quality lubricants such as engine and transmission oils. Crude oil processing will end at the Wesseling site by 2025 but will continue at the Godorf site. The high degree of electrification of the base oil plant, as well as the ceasing of crude oil processing into fuels at the Wesseling site, is expected to reduce Shell's scope 1 and 2 carbon emissions by around 620,000 tonnes a year. Shell's target is to become a net-zero emissions energy business by 2050. The new base oil plant is expected to start operations in the second half of this decade. Notes to editors:This investment, financed by Shell's Chemicals and Products business, meets the minimum acceptable internal rate of return set out at Capital Markets Day in 2023. Shell has already driven forward the transformation of the Energy and Chemicals Park Rheinland with investments in a 10-megawatt electrolyser to produce renewable hydrogen and a biomethane liquefaction plant. Despite ceasing crude oil processing at the Wesseling site, fuel supplies for the German market are expected to remain stable and secure.
|
BAH | Hot Stocks06:47 EST Booz Allen raises quarterly dividend to 51c from 47c per share - Payable on March 1 to shareholders of record on February 12.
|
MTAL | Hot Stocks06:38 EST Metals Acquisition provides update on listing on ASX progress - Metals Acquisition has been progressing a secondary listing on the Australian Securities Exchange, or ASX, and provided an update in relation to its proposed ASX listing. MAC has lodged a prospectus with the Australian Securities and Investments Commission on January 26 to undertake an initial public offering, or IPO, in Australia of CHESS depository interests, or CDIs, and to seek a dual listing on the ASX. In connection with the Listing, the Company is seeking to raise A$300M, or $197M, before costs through the issue of between 17,647,059 - 18,750,000 CDIs, equivalent to between 17,647,059 - 18,750,000 ordinary shares in the capital of the Company, representing a ratio of one CDI for one Share. The offer comprises: the Institutional Offer which consists of an offer to certain institutional investors in Australia, New Zealand and certain other non-US jurisdictions around the world; the Broker Firm Offer which is open to Australian resident retail clients of participating brokers, who have a registered address in Australia and who receive an invitation from a broker to acquire CDIs under the Prospectus; and the Priority Offer which is open to select investors nominated by the Company in eligible jurisdictions, who receive a Priority Offer invitation. The final price for the issue CDIs under the Offer will be determined through a bookbuild process, with the indicative price range of the Offer having been set at A$16.00-A$17.00 or $10.52-$11.18 per CDI. The Broker Firm and Priority Offers are currently scheduled to formally open on 5 February 2024 and are expected to close on 9 February 2024. The proceeds of the Offer will be used to provide funds to repay Glencore's deferred consideration facility; increase working capital to facilitate operational flexibility and potential production growth; provide additional funding for exploration programs and mine development at the CSA Copper Mine; and fund the costs of the Offer and other administrative costs expected to be incurred by the Company. Barrenjoey Markets and Canaccord Genuity are acting as joint lead managers to the IPO. Gilbert + Tobin, Skadden, Arps, Slate, Meagher & Flom and Ogier are acting as Australian, US and Jersey legal advisors to the Company in relation to the IPO.
|
HUT | Hot Stocks06:31 EST Hut 8 Corp. Chief Commercial Officer Matt Prusak leaving company on Jan. 31 - Hut 8 Corp. announced that Matt Prusak, Chief Commercial Officer of the company, will depart Hut 8 on January 31. As previously disclosed in filings from the Celsius Network LLC bankruptcy proceedings, Prusak will assume a new role as CEO of the new bitcoin mining company being formed upon emergence.
|
ALE | Hot Stocks06:31 EST Allete raises dividend 4.1% to 70.5c - ALLETE announced that its Board of Directors has increased the quarterly dividend on the company's common stock to 70.5c per share, a 4.1% percent increase. On an annual basis the increased dividend is equivalent to $2.82 per share. The regular quarterly dividend is payable March 1 to common shareholders of record at the close of business February 15.
|
LEVI | Hot Stocks06:05 EST Levi Strauss expects to reduce global corporate workforce by 10%-15% in H1 - In its earnings release yesterday, Levi Strauss & Co. announced in Q1, the company's Board of Directors endorsed a multi-year global productivity initiative, Project FUEL, designed to accelerate the execution of the company's Brand Led and DTC First strategies while fueling long-term profitable growth. In fiscal 2024, it is expected this initiative will generate net cost savings of $100M. The first phase of the global productivity initiative is expected to occur in the first half of 2024 and is expected to include a 10% to 15% reduction of its global corporate workforce. As a result, the Company expects to record estimated restructuring charges of $110M-$120M in the first quarter. Additional restructuring charges may be incurred as the company progresses further with this initiative.
|
JPM | Hot Stocks06:03 EST JPMorgan names Jennifer Piepszak, Troy Rohrbaugh as co-CEOs of C&I Bank - JPMorgan on Thursday announced that Jennifer Piepszak, Co-CEO of Consumer and Community Banking, and Troy Rohrbaugh, Co-head of Markets and Securities Services, will become Co-CEOs of the expanded Commercial & Investment Bank. Doug Petno, CEO of the Commercial Bank, will lead an expanded Commercial Banking business, which will also encompass the Global Corporate Banking group. Viswas Raghavan, Co-head of Global Investment Banking, will become sole head of the Global Investment Banking franchise, while his partner, Jim Casey, has informed the company of his desire to take on a new role in the firm, which will be announced shortly. Marc Badrichani, Co-head of Markets and Securities Services, has informed the company of his desire to pursue outside opportunities. Jason Sippel and Pranav Thakur will become Co-heads of the company's Markets Trading business. Tim Fitzgerald will continue to lead Securities Services and Takis Georgakopoulos, Head of Global Payments, will continue to lead that business. Marianne Lake, Co-CEO of CCB, will become sole CEO of that business. Mary Erdoes remains CEO of Asset & Wealth Management. "JPMorgan Chase is stronger today than it has ever been, and this is thanks to our hundreds of thousands of employees and our superb senior management team. I am also particularly blessed to have an exceptional partner in Daniel Pinto, our President and COO," said Jamie Dimon, Chairman and CEO.
|
VNDA | Hot Stocks05:35 EST Vanda Pharmaceuticals announces U.S. patent allowance for Ponvory - Vanda Pharmaceuticals announced that the U.S. Patent and Trademark Office has issued a notice of allowance for its Ponvory patent application, number 17/962,968, covering methods for reducing clinical management events before or during the treatment of multiple sclerosis and methods for reinitiating treatment after missed doses. When issued, this patent is anticipated to expire on October 10, 2042. Upon issuance, Vanda intends to list this patent in the FDA publication Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book.
|
YGF | Hot Stocks05:32 EST YanGuFang receives noncompliance notice from Nasdaq - YanGuFang announced that it received a deficiency notice from the Nasdaq. The deficiency cited by Nasdaq was due to the resignation of Jiangping Xiao, an independent director of the company, from the board of directors and the audit committee of the board. As a result of the resignation of Xiao, the company is no longer in compliance with Nasdaq's independent director and audit committee requirements as set forth in Listing Rule 5605. The notice states that, consistent with Listing Rule 5605(b)(1)(A) and 5605(c)(4), Nasdaq will provide the company a cure period until the earlier of the company's next annual shareholders' meeting or January 16, 2025 to regain compliance; provided that if the next annual shareholders' meeting is held before July 15, then the company must evidence compliance no later than July 15, 2024. If compliance is not achieved by the expiration of the cure period, the company's securities will be subject to delisting. At that time, the company may appeal the delisting determination to a Hearings Panel. The company plans to search for candidates and fill in the vacancy on the board and the audit committee within the cure period provided by Nasdaq. The notice has no immediate impact on the listing of the company's ordinary shares on Nasdaq.
|
RHHBY | Hot Stocks05:28 EST Genentech announces new 72-week data from BALATON, COMINO studies - Genentech, a member of Roche, announced new 72-week data from two global Phase III studies, BALATON and COMINO, evaluating Vabysmo in macular edema due to branch and central retinal vein occlusion. Whereas available RVO treatments are typically given every one to two months, the data showed nearly 60% of people receiving Vabysmo in BALATON and up to 48% of people in COMINO were able to extend their treatment intervals to three or four months apart. In addition, patients in the studies maintained vision gains and robust retinal drying achieved in the first 24 weeks of the studies for more than one year. Retinal drying is an important clinical measure as swelling from excess fluid in the back of the eye has been associated with distorted and blurred vision. In both studies, Vabysmo was well tolerated and the safety profile was consistent with previous studies. Results will be presented virtually on February 3 at Angiogenesis, Exudation, and Degeneration 2024, organized by Bascom Palmer Eye Institute in Florida. Both studies evaluated the average change in best-corrected visual acuity, or BCVA, score from baseline. The studies also tracked the amount of swelling in the back of the eye due to retinal fluid, as measured by central subfield thickness, or CST. Reductions in CST indicate improvement. Overall, results showed the vision improvements and reductions in retinal fluid achieved in the first 24 weeks of the studies were maintained up to 72 weeks. At 72 weeks, people receiving Vabysmo as a first-line treatment gained 18.1 letters on the eye chart, while people switched from aflibercept to Vabysmo gained 18.8 letters. During the first 24 weeks, vision gains were +16.8 eye chart letters in people receiving Vabysmo and +17.5 letters in people receiving aflibercept. At 72 weeks, people receiving Vabysmo as a first-line treatment saw a 310.9 microm reduction in retinal swelling, as measured by CST, while those switched from aflibercept to Vabysmo saw a reduction in CST of 307 microm. During the first 24 weeks of the study, CST reductions were 314.5 microm in people receiving Vabysmo and 307.6 microm in people receiving aflibercept. People receiving Vabysmo as a first-line treatment gained 16.9 eye chart letters at 72 weeks, while people switched from aflibercept to Vabysmo gained 17.1 eye chart letters. During the first 24 weeks of the study, vision gains were +16.9 eye chart letters in people receiving Vabysmo and +17.3 letters in people receiving aflibercept. People receiving Vabysmo as a first-line treatment saw a 465.9 microm reduction in retinal swelling, as measured by CST, while those switched from aflibercept to Vabysmo saw a reduction in CST of 460.6 microm at 72 weeks. During the first 24 weeks of the study, reductions in CST were 462.3 microm in people receiving Vabysmo and 447.8 microm in people receiving aflibercept.
|
CANG | Hot Stocks05:22 EST Cango, Caocao Mobility enter smart mobility partnership - Caocao Mobility and Cango announced a strategic partnership in smart mobility to explore areas including new car sales, used car transactions, financing services, and mobility offerings, marking the occasion with a signing ceremony. The parties said they are committed to fostering a next-generation smart mobility ecosystem by fully leveraging their respective advantages and resources and embracing their synergies.
|
ERIC | Hot Stocks05:17 EST Ericsson signs two funding agreements with EIB for EUR 420M - Ericsson is announcing that it has signed two agreements for funding with the European Investment Bank, or EIB, for a total of EUR 420M whereof EUR 250M was disbursed in December 2023. In addition to strengthening Ericsson's balance sheet and financial flexibility, the loans have been granted for the purpose of financing Ericsson's investments in research and development, or R&D, in relation to enhanced wireless technology between 2023 and 2025. The R&D investments are an important contributor into Ericsson's overall plan to reach the Net Zero target by 2040 through reduced energy consumption in the mobile networks globally. The loans form an important part of Ericsson's overall funding strategy, complementing other sources. In December 2023, Ericsson signed a seven-year EUR 100M green funding agreement with the Nordic Investment Bank, or NIB. The loan will finance R&D investments in wireless technology.
|
WETG | Hot Stocks05:10 EST WeTrade comments on lawsuit filed by individuals claiming to be shareholders - WeTrade issued a statement regarding the litigation initiated by individuals claiming to be shareholders associated with Zheng Dai and Pijun Liu in the Chancery Court of the State of Wyoming. The company said, "On January 5, 2024, the Chancery Court further entered into a preliminary injunction order. Specifically, the plaintiff-shareholders and their affiliates (included but not limited to Zheng Dai, Pijun Liu, Lina Jiang and their affiliates) are prohibited from engaging in the following activities: (i) representing themselves as majority shareholders, directors, executives or employees of the Company and its affiliates; (ii) attempting to contact regulatory bodies such as SEC or NASDAQ or making any filings or press releases on behalf of the Company; (iii) attempting to alter board composition and executive team; (iv) spreading false statements about the Company and its leadership; (v) trying to communicate with service providers of the Company including auditors, stock transfer agents, and filing agents; and (vi) issuing shares of the Company. The Company will take further legal action to safeguard the best interests of its shareholders, clients, and stakeholders. It will persistently concentrate on its core operations and strategic objectives, ensuring uninterrupted expansion and delivering substantial value to its investors."
|